Search for: "Does 1-12" Results 341 - 360 of 28,756
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Apr 2024, 6:07 am by Jonathan Panikoff
Israelis currently oppose the concept by an almost 2-to-1 margin; and international demands that a still-traumatized Israel agree to a near-term two-state solution are almost certain to backfire. [read post]
3 Apr 2024, 9:01 pm by renholding
After all, every lawyer here knows what the test is to determine whether a crypto asset was offered and sold as an “investment contract,” and therefore a security: it’s the Howey test.[1] It’s not the “essential ingredients” test,[2] or the Beanie Baby test,[3] or some other test that industry folks might like to create for themselves. [read post]
3 Apr 2024, 9:00 pm by Guest Contributor
Office of Regulatory Affairs (ORA) Associate Commissioner for Regulatory Affairs Michael Rogers on Wednesday, May 1 at 12:30 p.m. [read post]
3 Apr 2024, 4:08 pm by admin
… It certainly does not ensure that the work has been fully vetted in terms of the data analysis and the proper application of research methods. [read post]
3 Apr 2024, 1:42 pm by Rebecca Tushnet
Likewise, alleging that an “industry analyst ... noted that ‘these ISP businesses are being sold for an average multiple of 0.8x Sales and over 2x their fleet value’ ” does not “explain how the sales value of an ISP at one point in time demonstrates whether there has been a ‘pullback’ in a route’s value over a period of time. [read post]
3 Apr 2024, 1:37 pm by John B. Palley
He does a nice job incorporating humor into a tough subject… D-E-A-T-H! [read post]
3 Apr 2024, 12:44 pm by Robin E. Kobayashi
[LexisNexis Commentary: This IMR opinion is interesting because even though the clinical case summary does not indicate a diagnosis of fibromyalgia, the IMR reviewer applies the MTUS/ACOEM chronic pain guideline’s recommendation of weight loss for that condition (at page 224) “by analogy. [read post]
3 Apr 2024, 9:13 am by Dennis Crouch
Citations: [1] https://patentlyo.com/patent/2023/12/motion-remand-xencor.html [2] https://patentlyo.com/patent/2024/01/important-antibody-description.html [3] https://cafc.uscourts.gov/01-23-2024-23-2048-in-re-xencor-inc-order-23-2048-order-1-23-2024_2257719/ [read post]
3 Apr 2024, 8:29 am by Dennis Crouch
Patent No. 1,877,504, issued to Dow Chemical employees John Grebe and Ross Sanford on September 12, 1932. [read post]
3 Apr 2024, 3:00 am by Meredith Ervine
– Delayed Form S-3 Eligibility: the post-merger combined company will not be Form S-3 eligible until 12 full calendar months after closing of the RM (e.g., similar to an IPO, the combined company needs “seasoning” through 12 calendar months of SEC reporting). [read post]
2 Apr 2024, 10:30 pm by Sophie Stalla-Bourdillon
Its final text was published on 12 October 2022, and it officially entered into force on 1 November 2022. [read post]
2 Apr 2024, 12:56 pm by admin
Ioannidis “Why Most Published Research Findings Are False,” 1 PLoS Med 8 (2005). [3] Joseph P. [read post]